Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)

1 Jan 2013

Abstract excerpt

OBJECTIVE: Our goal was to evaluate the association of APOE with amyloid deposition, cerebrospinal fluid levels (CSF) of Aβ, tau, and p-tau, brain atrophy, cognition and cognitive complaints in E-MCI patients and cognitively healthy older adults (HC) in the ADNI-2 cohort. METHODS: Two-hundred and nine E-MCI and 123 HC participants from the ADNI-2 cohort were included. We evaluated the impact of diagnostic status...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Intracerebral and Subarachnoid Hemorrhage Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23554593
DOI: 10.3389/fnagi.2013.00011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)PMID 23554593Read ↗

Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.Semantic proximity Read ↗

Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.Semantic proximity Read ↗

Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.Semantic proximity Read ↗

APOE and amyloid-tau pathology in cognitively unimpaired older adultsSemantic proximity Read ↗

Differences in AD-related pathology profiles across APOE groupsSemantic proximity Read ↗

Effects of APOE ε4 and amyloid pathology on longitudinal tau biomarkers, neurodegeneration, and cognitive decline in mild cognitive impairment.Semantic proximity Read ↗

Impact of APOE in mild cognitive impairment.Semantic proximity Read ↗

Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.Semantic proximity Read ↗

APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern.Semantic proximity Read ↗

Sex differences in the association between apolipoprotein E ε4 allele and Alzheimer's disease markersSemantic proximity Read ↗

Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.Semantic proximity Read ↗

APOE ε4–associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuumSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.